The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer

In Vivo. 2022 Mar-Apr;36(2):814-820. doi: 10.21873/invivo.12768.

Abstract

Background/aim: Clinicopathological features of patients undergoing margin enlargement after lumpectomy for early breast cancer with positive/close excision margins were analyzed in order to define whether a re-operative procedure could have been avoided. Furthermore, a standardized protocol of specimen orientation was adopted in order to optimize both the widening procedure as well as the oncologic outcome.

Patients and methods: A retrospective analysis was performed including pre-, peri-, and post-operative parameters, and a predictive score by means of a multivariate model was developed using all clinically and statistically significant variables associated with residual disease (RD).

Results: RD was significantly related to positive tumor margins, hormone receptor negative, HER2-positive, and tumors with high Ki67 proliferation index (p<0.001); the corresponding contribution to the prognostic score was as follows: close margins, 3 points; hormone receptor positive disease, 2 points; low Ki67, 2 points; HER2 negativity, 1 point. In 102 patients with a score >3, only 2 patients (2.0%) had RD, while in 81 patients with a score ≤3, 55 patients (67.9%) had RD (p<0.001).

Conclusion: This predictive model might aid in clinical-decision making of patients with positive margins who actually require a widening procedure after intraoperative and/or definitive histology.

Keywords: Breast cancer surgery; excision margin; intraoperative pathologic examination.

MeSH terms

  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / surgery
  • Carcinoma, Ductal, Breast* / pathology
  • Female
  • Humans
  • Margins of Excision
  • Mastectomy, Segmental
  • Neoplasm Recurrence, Local / pathology
  • Reoperation
  • Retrospective Studies
  • Risk Factors